Phase II study of dianhydrogalactitol and ICRF-159 in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy

Cancer Treat Rep. 1977 Jan-Feb;61(1):81-2.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Clinical Trials as Topic
  • Drug Evaluation
  • Ethers, Cyclic / therapeutic use
  • Female
  • Follow-Up Studies
  • Galactitol / analogs & derivatives
  • Galactitol / therapeutic use*
  • Humans
  • Mitolactol / therapeutic use
  • Piperazines / therapeutic use*
  • Razoxane / therapeutic use*
  • Sugar Alcohols / therapeutic use*

Substances

  • Ethers, Cyclic
  • Piperazines
  • Sugar Alcohols
  • Galactitol
  • Razoxane
  • Mitolactol